| Age (years) |
52.8 (9.8) |
51.1 (10.2) |
|
|
|
| Gender (female) |
294 (52%) |
41 (82%) |
|
|
|
| Time to follow up (years) |
12.1 (1.2) |
12.2 (1.0) |
|
|
|
| Total number of conditions |
1.7 (1.7) |
2.2 (1.8) |
|
|
|
| Asthma |
54 (9.6%) |
6 (12%) |
|
|
|
| COPD |
8 (1.4%) |
2 (4.0%) |
|
|
|
| Heart disease |
40 (7.1%) |
3 (6.0%) |
|
|
|
| Hypertension |
131 (23%) |
13 (26%) |
|
|
|
| Hyperlipidemia |
220 (39%) |
20 (40%) |
|
|
|
| Anemia |
64 (11%) |
8 (16%) |
|
|
|
| Thrombosis |
19 (3.4%) |
3 (6.0%) |
|
|
|
| TIA/Stroke |
13 (2.3%) |
3 (6.0%) |
|
|
|
| Peptic ulcer disease |
16 (2.9%) |
5 (10%) |
|
|
|
| Cirrhosis/Liver disease |
7 (1.2%) |
0 (0%) |
|
|
|
| Diabetes |
43 (7.7%) |
0 (0%) |
|
|
|
| Thyroid disease |
65 (12%) |
9 (18%) |
|
|
|
| Cancer |
61 (11%) |
0 (0%) |
|
|
|
| Arthritis |
120 (21%) |
14 (28%) |
|
|
|
| Glaucoma |
11 (2.0%) |
2 (4.0%) |
|
|
|
| Depression |
77 (14%) |
20 (40%) |
|
|
|
| Number of prescription medications |
3.7 (3.3) |
5.2 (4.7) |
1.3 |
0.4, 2.2 |
0.006 |
| Polypharmacy |
186 (33%) |
26 (52%) |
2.2 |
1.1, 4.4 |
0.024 |